Beta-cell autophagy under the scope of hypoglycemic drugs; possible mechanism as a novel therapeutic target
Obesity and metabolism · 19.02.2022 · 18 (4) · 465-470
DOI: 10.14341/omet12778 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity and metabolism, online erschienen am 19.02.2022. Verfasst von B. A. Marzoog und 1 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 74 Literaturangaben.
Abstract (Originalsprache)
Physiologically, autophagy is a major protective mechanism of β-cells from apoptosis, through can reserve normal β- cell mass and inhibit the progression of β-cells destruction. Beta-cell mass can be affected by differentiation from progenitors and de-differentiation as well as self-renewal and apoptosis. Shred evidence indicated that hypoglycemic drugs can induce β-cell proliferation capacity and neogenesis via autophagy stimulation. However, prolonged use of selective hypoglycemic drugs has induced pancreatitis besides several other factors that contribute to β-cell destruction and apoptosis initiation. Interestingly, some nonhypoglycemic medications possess the same effects on β-cells but depending on the combination of these drugs and the duration of exposure to β-cells. The paper comprehensively illustrates the role of the hypoglycemic drugs on the insulin-producing cells and the pathogeneses of β-cell destruction in type 2 diabetes mellitus, in addition to the regulation mechanisms of β-cells division in norm and pathology. The grasping of the hypoglycemic drug’s role in beta-cell is clinically crucial to evaluate novel therapeutic targets such as new signaling pathways. The present paper addresses a new strategy for diabetes mellitus management via targeting specific autophagy inducer factors (transcription factors, genes, lipid molecules, etc.).
Zitieren
APA
Marzoog, B. A., & Vlasova, T. I. (2022). Beta-cell autophagy under the scope of hypoglycemic drugs; possible mechanism as a novel therapeutic target. Obesity and metabolism, 18(4), 465-470. https://doi.org/10.14341/omet12778
Vancouver
Marzoog BA, Vlasova TI. Beta-cell autophagy under the scope of hypoglycemic drugs; possible mechanism as a novel therapeutic target. Obesity and metabolism. 2022;18(4):465-470. doi:10.14341/omet12778
BibTeX
@article{Marzoog2022,
author = {Marzoog, B. A. and Vlasova, T. I.},
title = {Beta-cell autophagy under the scope of hypoglycemic drugs; possible mechanism as a novel therapeutic target},
journal = {Obesity and metabolism},
year = {2022},
volume = {18},
number = {4},
pages = {465--470},
doi = {10.14341/omet12778}
}
EUVIMED